Every 424B that Health In Tech, Inc. (HIT) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow HIT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HIT filings page.
Health In Tech, Inc. (HIT) registered up to 34,224,247 shares of Class A common stock for resale by Yorkville. The shares may be issued under a Standby Equity Purchase Agreement: up to 9,532,889 on note conversion and up to 24,691,358 in Advances at HIT’s discretion. HIT receives no proceeds from Yorkville resales, but may receive up to $20.0 million in gross proceeds from stock sales to Yorkville. While note amounts are outstanding, Advance proceeds go solely to repayment unless Yorkville agrees otherwise; afterward, HIT expects proceeds primarily for sales and distribution expansion, technology and product development, operations and working capital. If all 34,224,247 registered shares were issued and outstanding, they would equal approximately 39.0% of common shares outstanding as of October 6, 2026.
Nasdaq limits issuance and note conversions to 13,100,378 shares, or 19.99% of Class A and Class B shares outstanding before the SEPA, absent stockholder approval; a separate 4.99% beneficial-ownership limit applies. HIT disclosed Nasdaq notices stating that its board and audit committee did not meet specified independence and membership requirements and that its closing bid price had been below $1.00 for 30 consecutive business days. The notices had no immediate effect on listing; the bid-price compliance deadline is April 12, 2027, and a reverse split is one option HIT identified.
Health In Tech, Inc., an AI-enabled insurance technology platform, has filed a mixed shelf registration allowing it to offer, from time to time, up to $300,000,000 of common stock, preferred stock, warrants, debt securities, subscription rights and units. The securities may be sold in one or more offerings with specific terms set in future prospectus supplements.
Because public float is about $23.3 million, SEC “Baby Shelf” rules currently cap primary sales under this shelf to roughly $7.8 million in any 12‑month period until float reaches $75 million. Class A common stock trades on Nasdaq as “HIT,” last reported at $1.07 per share on July 28, 2026.
Net proceeds from any offering are expected to be used for general corporate purposes, including working capital, capital expenditures, research and development and potential acquisitions. The company highlights dilution risk, potential pressure on its share price from future issuances, and limitations imposed by Baby Shelf rules. HI Card, a non-material platform, is currently paused with no 2025 revenue, with plans for a possible relaunch as a standalone service.
Health In Tech, Inc. has filed a prospectus to register for resale up to 5,600,000 shares of Class A Common Stock acquired by selling stockholders in a PIPE offering. The company will receive no proceeds from these resales; the selling stockholders will receive all proceeds. Shares outstanding were 53,842,109 as of May 21, 2026. The prospectus states the resale shares may be sold from time to time through underwriters, brokers, dealers or directly, and that sales could occur at prevailing or negotiated prices. The company disclosed the PIPE closed on March 27, 2026 and generated gross proceeds of $7.0 million to the company. The filing lists representative selling holders and shows per‑holder examples including holdings of 800,000, 800,000 and 2,400,000 shares for named holders. The registration is being filed pursuant to a registration rights agreement and will remain effective until the registered shares can be resold without restrictions or all registered shares are sold.